Abstract. In this study, 2-aminophenoxazine-3-one (Phx-3) exhibited a potent cell growth inhibitory effect with apoptotic features in a dose-dependent manner in various cancer cell lines tested. Comparison of the expression profiles of endoplasmic reticulum (ER) stress-related genes in U266 multiple myeloma cells after treatment with Phx-3 and the ER stress inducers tunicamycin (TNM) and thapsigargin (TPG) indicated that although TNM and TPG potently induced pro-apoptotic transcription factor CHOP (GADD153) within 8 h of treatment, Phx-3 induced almost no CHOP within 48 h of treatment in U266 cells. However, murine embryonic fibroblast (MEF) cells and other cancer cell lines (e.g. A549 lung cancer cells and HL-60 acute leukemia cells) exhibited up-regulation of CHOP after treatment with Phx-3. The potency of CHOP induction in response to Phx-3 appeared to be partially correlated with the cytotoxic sensitivity of Phx-3 among various cell lines tested. MEF cells derived from CHOP knockout mice were more resistant to Phx-3 than wild-type MEF cells. Since Phx-3 has been shown to induce activation of NF-κB, a transcription factor functioning as a repressor of CHOP, we further treated U266 cells with a combination of Phx-3 and NF-κB inhibitors (e.g. BAY11-7082 or parthenolide). This enhanced cytotoxicity along with up-modulation of CHOP in U266 cells. These data suggest that ER stress-mediated CHOP induction by Phx-3 is involved in the cytotoxic effect. Regulation of CHOP expression appears to be a potent therapeutic target for cancer treatment.
Introduction
Endoplasmic reticulum (ER) is an organelle found in eukaryotic cells for such key functions as calcium sequestration, protein translation, folding and maturation. However, recent reports indicate that ER also has an important role as a sensor for cellular stress. It detects changes in cell homeostasis and responds by triggering signal transduction pathways, known as unfolded protein response (UPR) (1, 2) . Proteins that fail to adopt the correct conformation are retrotranslocated to the cytosol, and they are ubiquitinated and degraded by the 26S proteasome through ER-associated degradation. When the amount of unfolded protein exceeds the capacity of the system, the proteins begin to aggregate in the ER, triggering a programmed death pathway, usually via apoptosis by induction of proapoptotic proteins such as C/EBP homologous protein CHOP (GADD153) (1, 3) .
Phenoxazine compounds such as 2-aminophenoxazine-3-one (Phx-3) and 2-amino-4, 4α-dihydro-4α-7-demethyl-3H-phenoxazine-3-one (Phx-1) have been reported to exert an anti-cancer effect against various cancer cells, by inducing cell growth inhibition and apoptotic cell death (4-7). Phx-3 is an oxidative phenoxazine, the essential component of actinomycin D with strong anti-cancer activity. Along with apoptosis induction, Phx-3 induces mitochondrial depolarization and sustained JNK activation in U266 cells (8) . The cytotoxic effect of Phx-3 is preceded by a decrease in intracellular pH in human epidermoid carcinoma cell line KB-3-1 and human chronic myeloid leukemia cell line K562, as well as generating reactive oxygen species in lung adenocarcinoma cell lines (9) (10) (11) . Simultaneous induction of differentiation and apoptosis by Phx-3 was also reported in malignant melanoma G-361 cells, which produced melanin and induced nuclear chromatin condensation and DNA fragments in response to . In vivo experiments demonstrated that Phx-3 prevented pulmonary metastasis of mouse B16 melanoma cells (13) . In addition to anti-cancer activity, Phx-3 exhibits various biological activities, including a potent anti-inflammatory effect by suppressing the production of nitric oxide (NO) and prostaglandin E2 (14) , as well as immunosuppressive, anti-viral and anti-mycobacterial effects and the elimination of Helicobacter pylori (15) (16) (17) . All these biological effects suggest the potent therapeutic possibility of Phx-3. Although molecular-based mechanisms for these functions of Phx-3 are becoming evident, the pieces of the puzzle have not yet been clearly put together to explain the all diverse functions of Phx-3.
We recently reported that bortezomib (BZ), the 26S proteasome inhibitor approved for treatment of multiple myeloma Involvement of endoplasmic reticulum stress-mediated CHOP (GADD153) induction in the cytotoxicity of 2-aminophenoxazine-3-one in cancer cells (MM) , induces ER stress-mediated cell death along with up-modulation of CHOP (18) . BZ has been reported to inhibit NF-κB activity by inhibiting proteasome-mediated degradation of IκB, which is a negative regulatory compartment of NF-κB in cytoplasm. However, recent reports by us and others revealed that BZ did not inhibit, but rather activated, a canonical NF-κB pathway along with enhanced phosphorylation and degradation of IκBα (18, 19) . Therefore, ER stress may be a major cause of death in MM cells after exposure to BZ. Our previous study also revealed that Phx-3 activates a canonical NF-κB pathway with the induction of cytotoxicity in A549 lung cancer cells (11, 18) . In the present study, we further investigated whether Phx-3 treatment induces ER stress including CHOP induction, and how much ER stress is involved in the cytotoxicity of Phx-3 in tumor cells, including MM cells.
Materials and methods
Reagents. Phx-3 was prepared from the reactions of o-aminophenol with bovine hemoglobin solution, following the methods described by Tomoda et al (20) . Phx-3 was dissolved in a mixture of dimethyl sulfoxide (DMSO) and ethyl alcohol (3:1) as a vehicle to make 20 mM solution. BAY11-7082 was purchased from Calbiochem (Darmstadt, Germany), parthenolide and tunicamycin (TNM) were obtained from Sigma-Aldrich (St. Louis, MO), and thapsigargin (TPG) was purchased from Nacalai Tesque (Kyoto, Japan). These reagents were dissolved in DMSO.
Cell lines and culture conditions. For this study, U266 (a multiple myeloma cell line), HL-60 (an acute myeloid leukemia (AML) cell line), A549 (a lung adenocarcinoma cell line), COLO201 (a colon cancer cell line), U251MG (a glioblastoma cell line), a CHOP -/-MEF cell line designated CHOP-KO-DR established from a 13.5-day-old CHOP -/-mouse embryo by SV-40 immortalization and a CHOP +/+ MEF cell line designated DR-wild-type as a control cell line for CHOP-KO-DR were obtained from the American Type Culture Collection (Rockville, MD). Cell lines U266, HL-60 and COLO201 were maintained in continuous culture in RPMI-1640 medium (Gibco, Grand Island, NY) supplemented with 10% FBS (Gibco) 2 mM L-glutamine, penicillin (100 U/ml), and streptomycin (100 µg/ml) (Gibco). In addition, A549, U251MG and CHOP-KO-DR and DR-wild-type cells were maintained in Dulbecco's modified Eagle's medium (Sigma) supplemented with 10% FBS, penicillin (100 U/ml) and streptomycin (100 µg/ml) in a humidified incubator containing 5% CO 2 and 95% air at 37˚C.
Assessment of viable number of cells among cultured cells.
The number of viable cells was assessed by CellTiter Blue, a cell viability assay kit (Promega Co., Madison, WI), with fluorescence measurements at 570 nm for excitation and 590 nm for fluorescence emission.
Immunoblotting. Immunoblotting was performed as previously described (18) . In short, cells were lysed with RIPA Lysis Buffer (Santa Cruz Biotechnology Inc., Santa Cruz, CA) containing 1 mM PMSF, 0.15 U/ml aprotinin, 10 mM EDTA, 10 mg/ml sodium fluoride, and 2 mM sodium orthovanadate. Cellular proteins were quantified using a DC protein assay kit of Bio-Rad (Richmond, CA). Equal amounts of proteins were loaded onto the gels, separated by SDS-PAGE and transferred onto Immobilon-P membrane (Millipore Corp., Bedford, MA). The membranes were probed with first antibodies (Abs) such as anti-CHOP (GADD153) Ab, anti-GAPDH mAb and anti-β-actin mAb (Santa Cruz Biotechnology). Immunoreactive proteins were detected with horseradish peroxidase-conjugated second Abs and an enhanced chemiluminescence reagent (ECL) (Millipore). Densitometry was performed using a Molecular Imager, ChemiDoc XRS system (Bio-Rad).
Gene expression analysis. Total RNA was isolated from cell pellets using Isogen (Nippon Gene, Tokyo) and genomic DNA was removed using RQ1 RNase-Free DNase (Promega) at 37˚C for 30 min, followed by extraction with phenol chloroform and ethanol precipitation. Reverse-transcription using a PrimeScript RT Master Mix (Takara Bio Inc., Ohtsu, Japan) was performed according to the manufacturer's instructions. Real-time PCR was performed on 3 ng of cDNA using validated SYBR-green gene expression assays for human and murine ATF6, IRE1, PERK, GRP78, ATF4, CHOP, GADD34 and BCL-2 in combination with SYBR Premix Ex Taq II (Takara Bio Inc.). All primers used in this study are listed in Table I . Quantitative real-time PCR was performed in duplicates in a Thermal Cycler Dice real-time system TP800 (Takara Bio, Inc.) with the following conditions: initial cDNA denaturation at 95˚C for 30 sec, followed by 45 cycles of the sequence of denaturation at 95˚C for 5 sec and simultaneous annealing and extension at 60˚C for 30 sec. The data were analyzed using Thermal Cycler Dice real-time system software (Takara Bio, Inc.), and the comparative C t method (2 -ΔΔCt ) was used for relative quantification of gene expression. The data of real-time PCR products were standardized to GAPDH as an internal control. To confirm the specific amplification of target genes, each gene product after real-time PCR was further separated by 1.5% agarose gel to detect a single band at the theoretical product size, and the dissociation curves were analyzed to detect a single peak.
Statistics. All data are given as the mean ± SD. Statistical analysis was performed by using Mann-Whitney's U test (twotailed).
Results

Cell growth inhibition of Phx-3 in various cancer cell lines.
Phx-3 exhibited cell growth inhibition in a dose-dependent manner in various cancer cell lines tested and the MEF cell line (Fig. 1 ). Morphological studies of the cells after treatment with Phx-3 indicated typical features of apoptosis (e.g. chromatin condensation and nuclear fragments), as previously reported (data not shown) (5, 6) . Although cell growth inhibition was detected in all cell lines, A549 lung adenocarcinoma cells exhibited the most potent growth inhibition in response to Phx-3. U266 multiple myeloma cells were less sensitive to Phx-3 at concentrations of <10 µM, whereas MEF cells exhibited more potent cytotoxicity in response to Phx-3.
Profile of ER stress-related gene expression after exposure to
Phx-3 in U266 cells and MEF cells. We next examined whether ER stress-related genes are induced after treatment with Phx-3. First, we chose U266 cells, because our previous report demonstrated that ER stress was induced after treatment with BZ and other ER stress inducers, such as TNM and TPG (18) . As indicated in Table II , a series of ER stress-related genes were induced after treatment with TNM and TPG. While dramatically increased expressions of GRP78 and CHOP were observed within 8 h of with either TNM or TPG, induction of these genes resulted in minimal response after treatment with Phx-3. Immunoblotting with anti-CHOP Ab also demonstrated that TPG induced CHOP within 6 h of treatment, whereas Phx-3 showed no detectable CHOP in U266 cells during 48 h exposure (Fig. 2) .
Interestingly, comparison of the gene expression profiles of U266 and MEF cells, indicated that CHOP was strongly induced in MEF cells after treatment with Phx-3 (Table II, Fig. 3 ). This result indicates that MEF cells are more sensitive than U266 cells to ER stress induction by Phx-3. However, although CHOP was strongly induced, GRP78 was not induced by Phx-3 as much in MEF cells as by TNM or TPG treatment ( Fig. 3) . Therefore, ER stress was exactly induced in response to Phx-3 in MEF cells; however, the quality of ER stress appeared to differ between Phx-3 and TNM or TPG (Table II) . Next, we compared the ability to induce CHOP among various cell lines after treatment with Phx-3 and TMN. CHOP induction in response to Phx-3 varied among cell lines (Fig. 4) . However, MEF, A549 and HL-60 cells exhibited higher expression levels of CHOP (9-to 18-fold) than U266, COLO201 and U251MG cells (1-to 5.5-fold). Notably, except for COLO201 cells, sensitivity to Phx-3 in cell growth inhibition appears to be correlated in part with CHOP induction (Figs. 1 and 4) .
Involvement of CHOP induction for the cytotoxicity of Phx-3.
Our previous report suggested that ER stress-mediated CHOP induction was a major cause of cell death after treatment with BZ in U266 cells (18) . Since MEF cells were more sensitive to Phx-3 than U266 cells, and CHOP induction appeared to be related to cell growth inhibition by Phx-3 in part (Figs. 1 and 4), we investigated whether CHOP was involved in the cytotoxic effect by Phx-3 using a MEF cell line derived from CHOP knockout mouse embryo (21) . Immunoblottings with anti-CHOP Ab demonstrated that CHOP was up-modulated after treatment with Phx-3 or TNM in wild-type MEF cells, whereas CHOP was not detectable in CHOP-KO-DR cells (Fig. 5A ). As shown in Fig. 5B , CHOP-KO-DR cells derived from a CHOP -/-mouse were more resistant to Phx-3 than CHOP +/+ wild-type MEF cells.
Combined treatment with Phx-3 and NF-κB inhibitors enhances the cytotoxic effect in U266 cells.
All the data suggested that ER stress-mediated CHOP induction is, at least in part, involved in the cytotoxic effect of Phx-3. Since NF-κB has been reported to act as a repressor of CHOP (22) and our previous data demonstrated that Phx-3 activates an NF-κB pathway (11), we further examined whether combined treatment with Phx-3 and NF-κB inhibitor enhances cytotoxicity, along with up-modulation of CHOP in U266 cells. BAY11-7082, which inhibits phosphorylation of IκBα, and parthenolide, another inhibitor of IκB kinase (IKK) α and IKKβ (the upstream activators of the NF-κB pathway), both exhibited some growth inhibition in U266 cells (23, 24) . It was noteworthy that combined treatment with Phx-3 and either BAY11-7082 or parthenolide resulted in enhanced cytotoxicity, compared with cells treatment with Phx-3, BAY11-7082, or parthenolide alone (Fig. 6A) . In addition, combined treatment of U266 cells with Phx-3 and BAY11-7082 resulted in up-regulation of CHOP, compared with the cells treated with Phx-3 or BAY11-7082 alone (Fig. 6B ).
Discussion
A well-known pro-apoptotic component of UPRs is induction of the basic-leucine zipper transcription factor, CHOP, which is regulated by the PERK-ATF4 and ATF6 pathways under ER stress conditions. CHOP represses the expression of anti-apoptotic proteins Bcl-2 and Bnip3, as well as direct transcriptional induction and translocation to the ER membrane of Bim, a proapoptotic BH3-only protein of the Bcl-2 family (25) . It has been reported that overexpression of CHOP is sufficient to induce cell death in response to ER stress (25) . Therefore, CHOP is the key molecule for inducing apoptosis during ER stress (26). TNM, tunicamycin at 1 µg/ml; TPG, thapsigargin at 300 nM. Bold indicates more than 5-fold increased gene expression, compared with untreated cells. In the present study, we demonstrated that Phx-3 induced ER stress and up-regulated CHOP, although the expression levels varied among the cell lines tested. Myeloma cell line U266 indicated lower CHOP induction in response to Phx-3, whereas MEF cells exhibited higher levels ( Fig. 3 and Table II ). The extent of CHOP induction in response to Phx-3 in cell lines was partially correlated with sensitivity to cell growth inhibition by Phx-3. In addition, the MEF cell line derived from CHOP knockout mouse was far less sensitive in cytotoxicity to Phx-3 than the wild-type MEF cell line (Fig. 5B) . Therefore, all these data suggest that ER stress-mediated CHOP induction was involved in the cytotoxicity of Phx-3. Interestingly, although GRP78 was strongly induced in response to TNM and TPG, little induction of GRP78 was observed in response to Phx-3 even in MEF cells showing potent up-modulation of CHOP after Phx-3 treatment (Table IIB) . GRP78 interacts with the ER luminal domain of three stress sensors (e.g. PERK, IRE1 and ATF6); however, upon accumulation of unfolded proteins, GRP78 dissociates from these molecules, leading to their activation. As a chaperon, GRP78, which has a conserved ATPase domain and a peptide-binding domain, recognizes and binds to proteins with hydrophobic residues in the unfolded regions (25, 26) . Regarding GRP78 transcription, the GRP promoters contain multiple copies of the ER stress response element (ERSE) (27) . TPG, which blocks the ER calcium ATPase pump, thereby depleting the ER calcium store. TNM inhibits protein glycosylation by blocking the first step in the biosynthesis of N-linked oligo-A B saccharides in the ER and Golgi (28, 29) . ER stress-inducers (e.g. TPG and TNM) have been reported to promote TFII-I, a signal-induced multifunctional transcription factor, to bind to GRP78 promoter and enhance its transcriptional activity (30) . Currently, it is unclear how Phx-3 induces ER stress. It has been reported that Phx-3 induced a rapid decrease of intracellular pH (pHi) associated with the inhibition of Na + /H + exchanger isoform 1 (NHE1) in the plasma membrane of gastric cancer cell lines (9, 10) . The reduction of pHi precedes an apoptotic event in response to Phx-3 and greatly suppresses glycolysis in cancer cells, which may cause ER stress. However, the limited induction of GRP78 by Phx-3 in U266 and MEF cells shown in Table IIB suggests that the quality of signals toward ER stress caused by Phx-3 is different from the quality of those by TPG and TNM. Interestingly, both TMN and TPG, but not Phx-3, potently induce autophagy in various cell lines (personal observation by S.M. and K.M.). Regarding signals from ER stress to autophagy, ATF4, a transcription factor and a component of the PERK pathway, was reported to facilitate autophagy through direct binding to a cyclic AMP response element binding site in the LC3B promoter, following up-regulation of LC3B and autophagy induction in response to sever hypoxia (3, 31) . Up-regulation of ATF4 by TMN and TPG was indeed more prominent than by Phx-3 in MEF cells (Table IIB) . This result may also explain the difference in the quality in ER stress between Phx-3 and the other two agents, although the signals appear to converge to CHOP for induction of apoptosis.
A. U266 cells Fold change ± SD --------------------------------
We previously reported that Phx-3 activates NF-κB during the induction of apoptosis (11) . To clarify how NF-κB is activated by Phx-3, two pathways for NF-κB activation via ER stress were analyzed. In response to ER stress, a serine/threonine kinase PERK phosphorylates the eukaryotic translation initiation factor (eIF2α). This event results in the inhibition of most cap-dependent translation including IκB, followed by the activation of NF-κB (32) . In addition, IRE1α/TRAF2 can recruit the IκB kinase, which mediates the activation of NF-κB (33) . Therefore, activation of NF-κB in response to Phx-3 can be explained by ER stress-mediated pathways. However, NF-κB has also been reported to function as a suppressor of CHOP. Previous reports demonstrated that NF-κB promoted cell survival during ER stress by repressing CHOP expression via the p65 subunit but not the p50 subunit of NF-κB (22) . This finding was also supported by our data indicating that combined treatment with Phx-3 plus NF-κB inhibitors further enhanced cytotoxicity, along with up-modulation of CHOP in U266 cells (Fig. 6) . The lower expression level by Phx-3 in U266 cells may be explained by the repressor function of NF-κB for CHOP (Fig. 3) . Additionally, NF-κB activation during ER stress may function as a negative feed-back loop for regulating pro-apoptotic signals via CHOP repression.
All our data suggest that ER stress-mediated CHOP induction is involved in the cytotoxicity of Phx-3. Additionally, regulation of CHOP induction such as inhibition of NF-κB appears to be a potential therapeutic target for cancer treatment.
